Scientists have developed a new drug that can prevent migraines and headaches.
Erenumab is an injectable drug that can block the pain signals that are transmitted to the brain.
This soothing agent contains antibodies that act towards a receptor in the brain. The monthly injection that will prevent migraines may be available next year, writes huffingtonpost.co.uk.
When a protein associated with migraines sends painful signals during a seizure, Erenumab blocks the receptor, thus preventing the severe migraine headaches.
The drug halved the number of monthly migraines. The side effects are not yet known since no human patient has recorded one.
Migraine is a neurological disorder and is manifested by atrocious pain in one or both sides of the head.
In some cases, headache may be accompanied by other symptoms, including nausea, vomiting, numbness in the face.
Also, patients can experience light sensitivity and sound, even ocular problems.
There are four stages of migraine installation. It can be triggered many hours later from sending pain signals to the brain, this being the first phase.
The second phase includes sensory and visual disturbances that appear before the other symptoms. Only 20-25% of those who suffer from migraines experience this second phase.
The third or the attack phase is known as the headache, a pain that can last for several hours, even days!
The phase of the attack leads to the release of inflammatory substances, so the blood vessels become inflamed.
There is increased blood flow in the brain, and the feeling of being pulsating something in the head is a symptom found in many migraine-suffering patients.
Pain receptors are activated and send pain signals to different parts of the brain.
Untreated, migraine can last up to 72 hours! Follow the fourth phase of recovery. After intense pain, there is fatigue, weakness, and lack of concentration, unpleasant conditions that can last for two days until the brain returns to normal.